BIOMX INC's ticker is PHGE and the CUSIP is 09090D103. A total of 16 filers reported holding BIOMX INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $11,159 | -44.2% | 59,768 | 0.0% | 0.00% | – |
| Q3 2022 | $20,000 | +25.0% | 59,768 | +166.1% | 0.00% | – |
| Q2 2022 | $16,000 | -66.7% | 22,462 | -10.1% | 0.00% | – |
| Q1 2022 | $48,000 | -64.2% | 24,984 | -43.1% | 0.00% | – |
| Q3 2021 | $134,000 | -26.0% | 43,894 | +73.0% | 0.00% | – |
| Q1 2021 | $181,000 | +88.5% | 25,365 | +45.6% | 0.00% | – |
| Q2 2020 | $96,000 | – | 17,424 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 2,133,402 | $11,648,000 | 1.19% |
| MMCAP International Inc. SPC | 684,451 | $3,737,000 | 0.18% |
| Orbimed Advisors | 2,313,489 | $12,632,000 | 0.13% |
| Taylor Wealth Management Partners | 31,804 | $174,000 | 0.06% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 14,207 | $78,000 | 0.04% |
| ROYCE & ASSOCIATES LP | 359,000 | $1,960,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 104,000 | $568,000 | 0.01% |
| J. Goldman & Co LP | 150,000 | $92,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 427,702 | $2,335,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,060 | $6,000 | 0.00% |